A phase I study of nelmastobart (hSTC810), an anti-BTN1A1 antibody, in patients with advanced solid tumors

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2023
This article has no abstract
Epistemonikos ID: 8fa15f6b1caf21d475d58dd8593c64c950ae06a6
First added on: Feb 19, 2025